(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 38.69%2.2B | ---- | -26.16%1.58B | ---- | -2.63%2.14B | ---- | 9.37%2.2B | ---- | 6.44%2.01B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -17.59%-78.42M | ---- | -64.26%-66.69M | ---- | -44.71%-40.6M | ---- | -39.38%-28.06M | ---- | -12.94%-20.13M |
Interest expense - adjustment | ---- | 2.23%763.57M | ---- | 28.21%746.93M | ---- | 38.44%582.6M | ---- | 7.36%420.82M | ---- | 26.58%391.98M |
Dividend (income)- adjustment | ---- | 6.67%-36.63M | ---- | -23.75%-39.25M | ---- | -8.40%-31.72M | ---- | 4.11%-29.26M | ---- | 41.57%-30.52M |
Attributable subsidiary (profit) loss | ---- | -1,054.25%-683.19M | ---- | 93.18%-59.19M | ---- | -24.45%-867.24M | ---- | 6.15%-696.86M | ---- | -10.87%-742.53M |
Impairment and provisions: | ---- | 714.37%328.44M | ---- | -46.38%40.33M | ---- | 127.74%75.21M | ---- | -79.88%33.03M | ---- | 1,054.16%164.12M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | --8.94M | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | -44.37%22.44M | ---- | 542.81%40.33M | ---- | -81.00%6.27M | ---- | 104.86%33.03M | ---- | 13.37%16.12M |
-Impairment of goodwill | ---- | --306M | ---- | ---- | ---- | --60M | ---- | ---- | ---- | --148M |
Revaluation surplus: | ---- | 80.89%-101.57M | ---- | -248.19%-531.49M | ---- | --358.64M | ---- | ---- | ---- | 587.26%64.83M |
-Derivative financial instruments fair value (increase) | ---- | 80.89%-101.57M | ---- | -248.19%-531.49M | ---- | --358.64M | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 587.26%64.83M |
Asset sale loss (gain): | ---- | 3,652.53%54.03M | ---- | 94.32%-1.52M | ---- | -41,087.69%-26.77M | ---- | 98.86%-65K | ---- | 90.82%-5.71M |
-Loss (gain) from sale of subsidiary company | ---- | 13,030.69%36.37M | ---- | --277K | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 1,050.62%17.66M | ---- | 107.19%1.54M | ---- | -7,117.23%-21.36M | ---- | 90.92%-296K | ---- | 84.47%-3.26M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | 38.38%-3.33M | ---- | -2,441.56%-5.41M | ---- | 109.45%231K | ---- | 94.06%-2.45M |
Depreciation and amortization: | ---- | 16.49%1.07B | ---- | 5.79%918.13M | ---- | 13.85%867.9M | ---- | 9.97%762.34M | ---- | 13.97%693.25M |
-Amortization of intangible assets | ---- | -5.10%18.06M | ---- | -3.54%19.03M | ---- | 6.36%19.73M | ---- | -0.89%18.55M | ---- | -3.55%18.71M |
Exchange Loss (gain) | ---- | -631.21%-4M | ---- | 107.12%753K | ---- | -643.53%-10.57M | ---- | 96.55%-1.42M | ---- | -117.83%-41.27M |
Special items | ---- | -10,728.51%-632.18M | ---- | --5.95M | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | ---- | 10.72%2.88B | ---- | -14.89%2.6B | ---- | 14.61%3.05B | ---- | 7.04%2.66B | ---- | 11.05%2.49B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 204.74%74.36M | ---- | -16.05%-71M | ---- | -232.01%-61.18M | ---- | 16.92%-18.43M | ---- | -178.54%-22.18M |
Accounts receivable (increase)decrease | ---- | 106.36%52.19M | ---- | -662.52%-820.06M | ---- | 34.26%-107.55M | ---- | 55.61%-163.58M | ---- | 18.74%-368.52M |
Accounts payable increase (decrease) | ---- | -247.14%-694.34M | ---- | 246.39%471.9M | ---- | -55.58%136.23M | ---- | 117.60%306.72M | ---- | 161.63%140.95M |
Special items for working capital changes | ---- | -132.08%-86.86M | ---- | 31.72%270.71M | ---- | -0.84%205.52M | ---- | -35.13%207.26M | ---- | 250.44%319.52M |
Cash from business operations | ---- | -9.30%2.22B | ---- | -24.06%2.45B | ---- | 7.68%3.23B | ---- | 17.10%3B | ---- | 30.48%2.56B |
Other taxs | ---- | 42.26%-218.63M | ---- | 3.37%-378.62M | ---- | -8.42%-391.82M | ---- | 5.82%-361.39M | ---- | -9.75%-383.75M |
Interest paid - operating | ---- | 3.95%-702.06M | ---- | -25.94%-730.94M | ---- | -33.74%-580.39M | ---- | -3.13%-433.97M | ---- | -28.72%-420.81M |
Special items of business | 101.86%919.46M | ---- | 137.82%455.49M | ---- | -76.93%191.53M | ---- | -7.60%830.03M | ---- | 25.27%898.28M | ---- |
Net cash from operations | 101.86%919.46M | -2.91%1.3B | 137.82%455.49M | -40.54%1.34B | -76.93%191.53M | 2.42%2.25B | -7.60%830.03M | 25.47%2.2B | 25.27%898.28M | 36.58%1.75B |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 17.59%78.42M | ---- | 64.26%66.69M | ---- | 44.71%40.6M | ---- | 39.38%28.06M | ---- | 12.94%20.13M |
Dividend received - investment | 14.63%415.33M | 14.91%452.94M | -15.56%362.33M | 8.95%394.17M | 50.34%429.11M | -25.10%361.79M | 94.45%285.43M | 25.96%483.03M | -15.99%146.79M | 42.48%383.5M |
Loan receivable (increase) decrease | 176.68%164.5M | -29.43%43.19M | 45.95%59.46M | -26.09%61.21M | -41.38%40.74M | 18.97%82.81M | 355.94%69.49M | -26.71%69.6M | --15.24M | 203.94%94.96M |
Decrease in deposits (increase) | -585.98%-25.14M | -3,942.03%-125.6M | 128.04%5.17M | -96.78%3.27M | -97.26%2.27M | 351.23%101.56M | 400.63%82.92M | -437.55%-40.42M | 28.84%16.56M | -112.90%-7.52M |
Sale of fixed assets | 320.11%42.65M | 75.37%24.1M | 270.51%10.15M | -78.33%13.74M | --2.74M | 1,144.32%63.42M | ---- | -52.28%5.1M | ---- | -88.39%10.68M |
Purchase of fixed assets | -6.72%-2.05B | -39.93%-4.68B | -41.42%-1.92B | -22.41%-3.34B | -15.58%-1.36B | -17.86%-2.73B | -47.72%-1.17B | -5.13%-2.32B | 17.38%-795.17M | 4.68%-2.2B |
Selling intangible assets | ---- | ---- | ---- | 180.16%46.43M | --35.85M | 8,857.84%16.57M | ---- | -95.61%185K | ---- | -93.35%4.22M |
Purchase of intangible assets | 32.84%-7.93M | -54.63%-44.7M | -108.77%-11.81M | 45.53%-28.91M | 80.49%-5.66M | -3.26%-53.07M | 7.74%-29M | 58.06%-51.4M | 74.35%-31.43M | -3.48%-122.56M |
Sale of subsidiaries | --79.74M | 116.39%11.56M | ---- | -3,310.20%-70.56M | -3,204.40%-68.37M | ---2.07M | ---2.07M | ---- | ---- | ---- |
Acquisition of subsidiaries | 29.85%-155.52M | -3,615.60%-341.17M | -1,402.89%-221.71M | 99.83%-9.18M | 100.32%17.02M | -29,636.38%-5.37B | -29,021.61%-5.26B | 142.77%18.18M | --18.18M | ---42.51M |
Recovery of cash from investments | ---- | --5.36B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | -68.44%-55.36M | 50.47%-148.65M | 13.73%-32.87M | 18.91%-300.13M | 56.69%-38.1M | 44.92%-370.13M | 54.99%-87.96M | -307.10%-672M | -53.70%-195.43M | -19.55%-165.07M |
Other items in the investment business | -62.98%3.01M | ---- | -65.97%8.12M | ---- | 757.61%23.85M | ---- | -74.74%2.78M | ---- | 110.05%11.01M | -62.63%-185.5M |
Net cash from investment operations | 8.82%-1.59B | 120.09%635.96M | -89.63%-1.74B | 59.72%-3.17B | 84.97%-918.14M | -217.35%-7.86B | -650.46%-6.11B | -11.89%-2.48B | 28.20%-814.25M | -2.92%-2.21B |
Net cash before financing | 48.03%-668.12M | 206.07%1.94B | -76.93%-1.29B | 67.43%-1.83B | 86.24%-726.61M | -1,928.47%-5.61B | -6,384.44%-5.28B | 39.91%-276.32M | 120.15%84.03M | 46.94%-459.81M |
Cash flow from financing activities | ||||||||||
New borrowing | -52.79%5.18B | 25.10%14.12B | 35.55%10.96B | 1.56%11.29B | 0.14%8.09B | 227.06%11.11B | 438.28%8.08B | -66.57%3.4B | -79.64%1.5B | 58.92%10.16B |
Refund | 49.80%-4.46B | -68.28%-15.21B | -18.91%-8.89B | -40.80%-9.04B | -193.81%-7.47B | -132.64%-6.42B | -131.83%-2.54B | 70.49%-2.76B | 83.41%-1.1B | -73.15%-9.35B |
Issuing shares | ---- | -99.05%406K | -97.71%406K | -98.48%42.63M | --17.72M | --2.8B | ---- | ---- | ---- | ---- |
Dividends paid - financing | -4.22%-79.18M | -28.20%-342.61M | -0.60%-75.98M | -31.25%-267.26M | -22.03%-75.52M | -11.19%-203.63M | -58.40%-61.89M | -10.46%-183.14M | 30.87%-39.07M | 16.73%-165.8M |
Absorb investment income | ---- | 1.40%54.55M | ---- | -54.57%53.79M | 259.72%96.32M | 210.59%118.42M | 18.86%26.78M | -61.91%38.13M | --22.53M | -40.85%100.09M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---395K | ---- | ---- | ---- | ---- |
Other items of the financing business | -203.51%-43.33M | 447.00%43.77M | 35.53%41.86M | -226.32%-12.61M | 591.43%30.89M | --9.99M | -83.37%4.47M | ---- | -72.11%26.85M | 2,454.81%84.46M |
Net cash from financing operations | -70.79%498.04M | -185.76%-1.75B | 155.28%1.71B | -72.39%2.04B | -87.82%668M | 1,491.37%7.37B | 1,277.66%5.49B | -42.53%463.39M | -49.06%398.16M | -16.66%806.32M |
Effect of rate | 61.89%-89.56M | 61.85%-107.18M | -61.21%-235.03M | -469.25%-280.95M | -365.99%-145.8M | -25.00%76.09M | 388.41%54.81M | 593.59%101.45M | -14.35%-19.01M | 78.29%-20.55M |
Net Cash | -140.53%-170.08M | -9.56%190.39M | 816.03%419.68M | -88.10%210.51M | -128.63%-58.61M | 845.70%1.77B | -57.55%204.71M | -46.01%187.06M | 32.23%482.19M | 243.48%346.5M |
Begining period cash | 2.08%4.08B | -1.73%4B | -1.73%4B | 82.89%4.07B | 82.89%4.07B | 14.89%2.23B | 14.89%2.23B | 20.23%1.94B | 20.23%1.94B | 0.39%1.61B |
Cash at the end | -8.63%3.82B | 2.08%4.08B | 8.24%4.19B | -1.73%4B | 55.57%3.87B | 82.89%4.07B | 3.53%2.49B | 14.89%2.23B | 22.51%2.4B | 20.23%1.94B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data